158 related articles for article (PubMed ID: 33220932)
1. Myocardial Dysfunction in Cirrhotic Cardiomyopathy is Associated with Alterations of Phospholamban Phosphorylation and IL-6 Levels.
Gregolin CS; do Nascimento M; Borges de Souza SL; Ferreira Mota GA; Bomfim GF; de Azevedo Melo Luvizotto R; Sugizaki MM; Zanati Bazan SG; Salomé de Campos DH; Dias MC; Correa CR; Cicogna AC; Ferreira do Nascimento A
Arch Med Res; 2021 Apr; 52(3):284-293. PubMed ID: 33220932
[TBL] [Abstract][Full Text] [Related]
2. Cardiac dysfunction in sucrose-fed rats is associated with alterations of phospholamban phosphorylation and TNF-α levels.
Gregolin CS; do Nascimento M; de Souza SLB; Mota GAF; Luvizotto RAM; Sugizaki MM; Bazan SGZ; de Campos DHS; Camacho CRC; Cicogna AC; do Nascimento AF
Mol Cell Endocrinol; 2024 Aug; 589():112236. PubMed ID: 38608803
[TBL] [Abstract][Full Text] [Related]
3. Exercise Training Attenuates Cirrhotic Cardiomyopathy.
de Souza SLB; Mota GAF; Gregolin CS; do Nascimento M; Luvizotto RAM; Bazan SGZ; Sugizaki MM; Barbisan LF; Cicogna AC; do Nascimento AF
J Cardiovasc Transl Res; 2021 Aug; 14(4):674-684. PubMed ID: 32246321
[TBL] [Abstract][Full Text] [Related]
4. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Liu H; Ma Z; Lee SS
Gastroenterology; 2000 May; 118(5):937-44. PubMed ID: 10784593
[TBL] [Abstract][Full Text] [Related]
5. Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.
Saeedi Saravi SS; Ghazi-Khansari M; Ejtemaei Mehr S; Nobakht M; Mousavi SE; Dehpour AR
World J Gastroenterol; 2016 May; 22(19):4685-94. PubMed ID: 27217700
[TBL] [Abstract][Full Text] [Related]
6. Impaired oxidative metabolism and calcium mishandling underlie cardiac dysfunction in a rat model of post-acute isoproterenol-induced cardiomyopathy.
Willis BC; Salazar-Cantú A; Silva-Platas C; Fernández-Sada E; Villegas CA; Rios-Argaiz E; González-Serrano P; Sánchez LA; Guerrero-Beltrán CE; García N; Torre-Amione G; García-Rivas GJ; Altamirano J
Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H467-77. PubMed ID: 25527782
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy.
Liu H; Lee SS
Liver Int; 2008 May; 28(5):640-8. PubMed ID: 18346133
[TBL] [Abstract][Full Text] [Related]
8. Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.
Kim SY; Kim KH; Schilling JM; Leem J; Dhanani M; Head BP; Roth DM; Zemljic-Harpf AE; Patel HH
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G531-G541. PubMed ID: 31961720
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.
Bátkai S; Mukhopadhyay P; Harvey-White J; Kechrid R; Pacher P; Kunos G
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1689-95. PubMed ID: 17557913
[TBL] [Abstract][Full Text] [Related]
10. Involvement of L-type calcium channel and SERCA2a in myocardial dysfunction induced by obesity.
Leopoldo AS; Lima-Leopoldo AP; Sugizaki MM; do Nascimento AF; de Campos DH; Luvizotto Rde A; Castardeli E; Alves CA; Brum PC; Cicogna AC
J Cell Physiol; 2011 Nov; 226(11):2934-42. PubMed ID: 21302294
[TBL] [Abstract][Full Text] [Related]
11. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy.
Ward CA; Liu H; Lee SS
Gastroenterology; 2001 Nov; 121(5):1209-18. PubMed ID: 11677214
[TBL] [Abstract][Full Text] [Related]
12. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy.
Jaue DN; Ma Z; Lee SS
Hepatology; 1997 Jun; 25(6):1361-5. PubMed ID: 9185753
[TBL] [Abstract][Full Text] [Related]
13. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats.
Ma Z; Miyamoto A; Lee SS
Gastroenterology; 1996 Apr; 110(4):1191-8. PubMed ID: 8613009
[TBL] [Abstract][Full Text] [Related]
14. Myocardial remodeling after large infarcts in rat converts post rest-potentiation in force decay.
Bocalini DS; dos Santos L; Antonio EL; Santos AA; Davel AP; Rossoni LV; Vassalo DV; Tucci PJ
Arq Bras Cardiol; 2012 Mar; 98(3):243-51. PubMed ID: 22344675
[TBL] [Abstract][Full Text] [Related]
15. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat.
Liu H; Song D; Lee SS
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G68-74. PubMed ID: 11123199
[TBL] [Abstract][Full Text] [Related]
16. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy.
Ma Z; Lee SS; Meddings JB
J Hepatol; 1997 Apr; 26(4):904-12. PubMed ID: 9126806
[TBL] [Abstract][Full Text] [Related]
17. Exenatide promotes cardiac lncRNAs HOX transcript antisense RNA (HOTAIR) in Wistar rats with liver cirrhosis; a novel role of GLP-1 receptor agonists in cirrhotic cardiomyopathy.
El-Kharashi OA; Mohamed DI; Khairy E; Ezzat SF; Zaki WS
Eur J Pharmacol; 2019 Jul; 855():294-304. PubMed ID: 31100415
[TBL] [Abstract][Full Text] [Related]
18. M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3.
Wijesundera KK; Izawa T; Tennakoon AH; Murakami H; Golbar HM; Katou-Ichikawa C; Tanaka M; Kuwamura M; Yamate J
Exp Mol Pathol; 2014 Jun; 96(3):382-92. PubMed ID: 24747241
[TBL] [Abstract][Full Text] [Related]
19. Cirrhotic cardiomyopathy.
Ruiz-del-Árbol L; Serradilla R
World J Gastroenterol; 2015 Nov; 21(41):11502-21. PubMed ID: 26556983
[TBL] [Abstract][Full Text] [Related]
20. Cirrhotic cardiomyopathy: a cardiologist's perspective.
Gassanov N; Caglayan E; Semmo N; Massenkeil G; Er F
World J Gastroenterol; 2014 Nov; 20(42):15492-8. PubMed ID: 25400434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
